We have observed
11 EP applications
Vinca Raymonde Lardans
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 17, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE (CDK4/6) INHIBITOR AND AN MTOR INHIBITOR FOR TREATING CANCER
SALT(S) OF 7-CYCLOPENTYL-2 -(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE
PHARMACEUTICAL COMBINATION COMPRISING BINIMETINIB
ORAL FORMULATIONS OF DEFERASIROX
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK AND PIM